The NVAX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NVAX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The NVAX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View NVAX Detailed Price Forecast - CNN Money||View NVAX Detailed Summary - Google Finance|
|View NVAX Detailed Summary - Yahoo! Finance||View NVAX Stock Research & Analysis - Zacks.com|
|View NVAX Trends & Analysis - Trade-Ideas||View NVAX Major Holders - Barrons|
|View NVAX Call Transcripts - NASDAQ||View NVAX Breaking News & Analysis - Seeking Alpha|
|View NVAX Annual Report - CompanySpotlight.com||View NVAX OTC Short Report - OTCShortReport.com|
|View NVAX Fundamentals - TradeKing||View NVAX SEC Filings - Bar Chart|
|View Historical Prices for NVAX - The WSJ||View Performance/Total Return for NVAX - Morningstar|
|View the Analyst Estimates for NVAX - MarketWatch||View the Earnings History for NVAX - CNBC|
|View the NVAX Earnings - StockMarketWatch||View NVAX Buy or Sell Recommendations - MacroAxis|
|View the NVAX Bullish Patterns - American Bulls||View NVAX Short Pain Metrics - ShortPainBot.com|
|View NVAX Stock Mentions - StockTwits||View NVAX Stock Mentions - PennyStockTweets|
|View NVAX Stock Mentions - Twitter||View NVAX Investment Forum News - Investor Hub|
|View NVAX Stock Mentions - Yahoo! Message Board||View NVAX Stock Mentions - Seeking Alpha|
|View Insider Transactions for NVAX - SECform4.com||View Insider Transactions for NVAX - Insider Cow|
|View NVAX Major Holdings Summary - CNBC||View Insider Disclosure for NVAX - OTC Markets|
|View Insider Transactions for NVAX - Yahoo! Finance||View Institutional Holdings for NVAX - NASDAQ|
|View NVAX Stock Insight & Charts - FinViz.com||View NVAX Investment Charts - StockCharts.com|
|View NVAX Stock Overview & Charts - BarChart||View NVAX User Generated Charts - Trading View|
Analyzing Novavax’s Financial Performance
Posted on Thursday August 16, 2018
Novavax (NVAX) generated revenue of $10.77 million in the second quarter compared to $6.73 million in the comparable period in 2017. The increase in the company’s revenue resulted from a $2 million increase in the Bill and Melinda Gates Foundation grant revenue due to higher enrolment in Novavax’s Prepare trial and an additional $2 million from increased activities from Novavax AB. The general and administrative expenses incurred by Novavax decreased from $8.94 million in the second quarter of 2017 to $8.22 million in the second quarter of 2018.
Gauging Analysts’ Expectations for Novavax and Peers in August
Posted on Thursday August 16, 2018
Novavax (NVAX) is a clinical-stage biotechnology company focused on bringing to market recombinant nanoparticle vaccines and adjuvants. Novavax makes use of its proprietary recombinant nanoparticle vaccine technology and saponin-based adjuvant technology to develop vaccine candidates that target different infectious diseases, such as the respiratory syncytial virus and influenza. Novavax has entered into a key grant agreement with the Bill and Melinda Gates Foundation (or BMGF), which is the current source of its revenue.
5 Promising Vaccines in Development -- and the Stocks Poised to Profit From Them
Posted on Wednesday August 15, 2018
Nearly $5 billion in combined annual sales could be on the way from these top vaccines in development.
Why Novavax, Inc. Shares Are Soaring Today
Posted on Thursday August 09, 2018
The clinical-stage biotech provided good news for two key vaccines in its pipeline.